Janssen €150m expansion of biopharmaceutical supply chain in Ringaskiddy signals confidence

-Pace of regional infrastructure delivery must improve -

Commenting on today’s positive Janssen announcement, supported by IDA, CEO of Cork Chamber Conor Healy said:
“The announcement by Janssen Sciences Ireland of a €150m investment in expanding their biopharmaceutical supply chain facility, creating 180 new jobs and employing up to 300 people during the two-year construction period provides a strong endorsement of Cork’s successful life sciences and pharma sector.”
“Cork’s fast-growing capability in the life sciences sector will continue to play a key role in the region’s economic development, reflecting the regions reputation as an international hub for pharmaceutical progress. As we recover from the global pandemic it is vital that we continue to support the sector in expanding their manufacturing capacity and supply chains, not only as a vehicle to drive economic recovery but also to ensure all those requiring biomedicines are reached.”
“Meanwhile, as yet another private sector investment is made in Ringaskiddy, there must be pause for reflection on the pace of timelines relating to the M28 and other significant infrastructure in our region. We must look to isolate and resolve any process that obstructs, delays or frustrates progress. In our local authority planning, Bord Pleanála, courts, licensing and regulatory systems there must be better resources and efficient binding timelines.”